---
layout: post
title: "Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act"
date: 2026-02-05 19:09:27 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-08943
original_published: 2021-04-29 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 29, 2021 00:00 UTC
**Document Number:** 2021-08943

## Summary

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with Agency guidance documents pertaining to pharmacies, outsourcing facilities, and other entities with regard to human drug compounding, repackaging, and related activities.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/04/29/2021-08943/agency-information-collection-activities-proposed-collection-comment-request-human-drug-compounding)
- API: https://www.federalregister.gov/api/v1/documents/2021-08943

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
